Dr. Atul K. Chawla, MD

Dr. Chawla practices at Select Specialty Hospital - Des Moines in Des Moines, Iowa, part of Select Medical Holdings.

Dr. Chawla's NPI, 1700868080, was assigned on November 14, 2005. Dr. Chawla holds Iowa license 31066.

Dr. Chawla's primary practice is Select Specialty Hospital - Des Moines, at 1111 6th Avenue, 4th Floor Main, Des Moines, IA 50314 in Polk County. The practice phone is (515) 247-4400.

Dr. Chawla's primary practice is Select Specialty Hospital - Des Moines in Des Moines, Iowa, part of Select Medical Holdings. Dr. Chawla is also affiliated with MercyOne Des Moines Medical Center. The medical group on file is MercyOne Iowa Heart Center. Dmand AI also links Dr. Chawla to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Chawla practices, 7 sites in all. Vendor and product names are available with a free account.

Interventional cardiology is Dr. Chawla's primary specialty in the NPI Registry, under taxonomy code 207RI0011X. Dr. Chawla is licensed in Iowa.

CMS data shows 1,237 Medicare services from Dr. Chawla across 19 procedure codes in 2024, for 625 Medicare patients. Medicare paid $117,378 for them.

CMS counts 625 Medicare patients who saw Dr. Chawla in 2024. The largest group is 75 to 84, with 264 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 6% are also on Medicaid. Their average risk score is 1.50, where 1.00 is the Medicare average.

Across all payers, Dmand AI patient panel data puts Dr. Chawla's median patient age at 77, with 41% women.

In 2024, Dr. Chawla wrote 1,389 Medicare Part D claims for 282 patients. 84% of them were for generic drugs. CMS names the drug for 1,264 of them, across 28 drugs with 11 or more claims each, at $123,210 in total drug cost. In 2023, CMS named 1,069 claims across 26 drugs.

Dr. Chawla accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS counts 47 procedures of coronary angioplasty and stenting by Dr. Chawla, more than 82% of the clinicians it reports for that procedure.

Dmand AI links 8 papers to Dr. Chawla, published from 2020 to 2024. The most frequent topics are Aortic Valve, Aortic Valve Stenosis and Heart Valve Prosthesis Implantation. Dr. Chawla has published most often in JACC Cardiovasc Interv. Dr. Chawla's most frequent co-authors are Mubashir Ahmed Mumtaz, MD, Hemal G. Gada, MD and Jeffrey J. Popma, MD.

Dmand AI links Dr. Chawla to 6 clinical trials. 5 are still active or recruiting. Conditions studied include Ventricular Outflow Obstruction, Aortic Valve Stenosis and Bicuspid Aortic Valve Disease. Medtronic Cardiovascular sponsors the most, 4.

CMS Open Payments shows 671 general payments to Dr. Chawla from 31 drug and device companies from 2016 to 2025. Speaker and faculty fees make up the largest share, 66% of the total. Medtronic Vascular, Inc. paid the most, $148,002.